Drug implementation

Identify all high-alert drugs available at the facility Implement processes to identify new medications for placement on the list Develop guidelines, dosing scales, and checklists for all high-alert drugs Implement a process to audit compliance with the protocols and guidelines... 

Most practical implementations of drug-likeness use a computational model which takes as input the molecular structure, together with various properties, and predicts whether the molecule is drug-like or not. Some of these models may be very simple, such as a series of substructural filters. Only those molecules which pass all of these filters are output, Such filters can be used to eliminate molecules that contain inappropriate functionality. 

Hygiene and Regulation Almost unique to MF is the influence of regulatoiy concerns in selec tion and implementation of a suitable microfilter. Since MF is heavily involved with industries regulated by the Food and Drug Administration, concerns about process stabihty, consistency of manufacture, virus reduc tion, pathogen control, and material safety loom far larger than is usually found in other membrane separations. 

Much legislation enacted by governments relating to such matters as pollution of the atmosphere and of rivers, the monitoring of foodstuffs, the control of substances hazardous to health, the misuse of drugs, and many others are dependent upon the work of analytical chemists for implementation. 

Discuss assessment, nursing diagnosis, planning, implementation, and evaluation as they apply to the administration of drugs. 

The nursing process is a framework for nursing action consisting of problem-solving steps that help members of the health care team provide effective patient care. It is both a specific and orderly plan used to identify patient problems, develop and implement a plan of action, and then evaluate the results of nursing activities, including the administration of drug . 

To evaluate die patient s response to tiierapy, and depending on die drug administered, die nurse may check die patient s blood pressure every hour, inquire whether pain has been relieved, or monitor die pulse every 15 minutes. After evaluation, certain otiier decisions may need to be made and plans of action implemented. For example, die nurse may need to notify die primary health care provider of a marked change in a patient s pulse and respiratory rate after a drug was administered, or die nurse may need to change die bed linen because sweating occurred after a drug used to lower die patient s elevated temperature was administered. 

A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost effectiveness. Individual chapters address in more detail all available drug classes and outline new approaches currently under development. 

Within this chapter we provide an assessment of the rationale behind the adoption of an ELN system, an overview of the current market for such systems, and the typical uses and key benefits for drug discovery to be derived from a successful implementation. 

Over the last 5 or 6 years there has been a marked increase in the number of companies implementing an ELN system within drug discovery. There has also been a corresponding increase in the number of companies providing commercial applications in this market sector (see Section 9.6 for more details). Initially this adoption of ELNs was done despite the problem of e-signatures, but lately more companies are moving to a fully electronic process, with the associated benefits that this proffers. 

A number of approaches have been made to justifying the implementation of IT systems within drug discovery, and ELN is no exception, although these systems do seem to have generated something of their own mythology in terms of return-on-investment ( ROl ) and other justification methods. What is clear from our work with major pharmaceutical customers is that there is broad acceptance of the benefits to be accrued from implementation of an ELN. The areas of benefit at which the majority of customers have looked are ... 

This project was slightly unusual, in that the success and ROI criteria were investigated and developed ahead of the rest of the project. This led to a project that had clear goals and milestones in terms of usability and performance, set out ahead of any review of available solutions. In addition, the project had measurable criteria for the impact that the system was having on the efficiency of the drug discovery process. These criteria were then also used to establish go/no-go criteria for the implementation project. 

One early step in the workflow of the medicinal chemist is to computationally search for similar compounds to known actives that are either available in internal inventory or commercially available somewhere in the world, that is, to perform similarity and substructure searches on the worldwide databases of available compounds. It is in the interest of all drug discovery programs to develop a formal process to search for such compounds and place them into the bioassays for both lead generation and analog-based lead optimization. To this end, various similarity search algorithms (both 2D and 3D) should be implemented and delivered directly to the medicinal chemist. These algorithms often prove complementary to each other in terms of the chemical diversity of the resulted compounds [8]. 

Rosenberg MJ. The promise and practice of technology implementing electronic development systems. Curr Drug Discov 2001 25-8. 

---